Alzheimer’s disease is currently treated primarily with acetylcholinesterase (AChE) inhibitors, which can increase the concentration of acetylcholine in the brain, thus ameliorating the cognitive and mental decline associated with this neurodegenerative disease (2). Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.